Skip to content
TrialScanner

NCT01490086

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Phase 2CompletedRVPHLead

Registry record

Lead sponsor
Reviva Pharmaceuticals
Conditions
Acute Schizophrenia; Schizoaffective Disorder
Primary completion
Mar 2013Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01490086 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01490086: RP5063 in Subjects With... | TrialScanner